Skip to main content
. 2021 Dec 18;12:187. doi: 10.1186/s13244-021-01123-1

Fig. 3.

Fig. 3

Studies reporting the percentage difference in ADC for pCR and non-pCR from baseline for the general study population at different time points. Note: The period of a cycle of neoadjuvant therapy (number of weeks) can differ within and between studies as well as the total number of cycles